Materialise NV Q3 2024 Financial Results

Materialise NV (NASDAQ:MTLS), a leading provider of 3D printing services and software solutions, reported solid financial performance in Q3 2024, with revenues climbing to €68.7 million, a 14% increase from the previous year. The medical segment stood out, contributing 44% to total revenue and growing over 24%. Gross margin improved to 57.2%, yielding an adjusted EBIT of €4.4 million (6.4% of revenue) and a net profit of €3 million (€0.05 per share). The net cash position strengthened to €63.1 million by quarter-end.

Key Takeaways

• Q3 2024 revenue increased by 14% year-over-year to €68.7 million.
• Medical segment grew over 24%, now representing 44% of total revenue.
• Gross margin rose to 57.2%, with adjusted EBIT of €4.4 million.
• Net profit stood at €3 million (€0.05 per share).
• Year-to-date revenue reached €201 million, with a net cash position of €63.1 million.
• Materialise maintains a positive growth outlook for the remainder of 2024.

Company Outlook

• Full-year revenue guidance is set between €265 million and €275 million.
• Adjusted EBIT guidance for 2024 projects between €11 million and €14 million.
• Expect moderate increases in operational expenses due to rising personnel costs.

Segment Highlights

Bearish Highlights

• Manufacturing segment faced challenges in prototyping demand, lowering adjusted EBITDA to €4.7 million (2.6% margin).
• Integration costs and startup negatives from the new ACTech plant may impact earnings.

Bullish Highlights

• Medical segment's adjusted EBITDA reached €9.9 million (32.8% margin), driven by strong growth in medical devices and software.
• Software segment saw a 3% revenue increase, while manufacturing grew by 9%.

Q&A Highlights

• The company is focused on transitioning the manufacturing segment from prototyping to end-use parts.
• Partnerships in the software segment are seen as a path to future growth, though guidance for upcoming quarters wasn’t specified.
• Transitioning from perpetual customers to a subscription model in the software segment will require time.

Materialise's recent earnings call underscored the company's successful initiatives in the medical sector, particularly in trauma care, and introduced cloud-based solutions like Mimics Flow. Strategic partnerships and the launch of Materialise Magics 28 are expected to boost growth moving forward. The new ACTech plant aims to enhance manufacturing capacities for complex metal parts, with management expressing confidence in continued growth for the year.

InvestingPro Insights

Materialise NV's strong Q3 2024 performance aligns with real-time data from InvestingPro, showcasing a revenue growth of 27.83% in Q3, in line with the 14% increase reported. The gross profit margin of 57.06% for the last twelve months is similar to the reported Q3 figure, indicating sustained profitability. Materialise has more cash than debt, supporting future investments or expansion. Stock performance is notable, with recent returns of 16.67% in the last week and 14.02% over the past month, driven by solid financial results and an optimistic outlook for the remainder of the year.